Table: Hisamitsu -Q1 group results

Hisamitsu Pharmaceutical Co

07/07/2022 07:00

Jul 7 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  May 31, 2022        May 31, 2021     Feb 28, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               26.39               27.76           123.00    
                   (-4.9 pct)          (+11.6 pct)      (+2.3 pct)  
  Operating          519 mln               2.12            11.10    
                   (-75.5 pct)         (+96.6 pct)      (+18.9 pct) 
  Recurring            2.30                2.86            12.70    
                   (-19.5 pct)        (+582.9 pct)      (+0.5 pct)  
  Net                  1.63                2.36             9.70    
                   (-30.9 pct)        (+1979.9 pct)     (+0.4 pct)  
  EPS               20.46 yen           28.91 yen       121.65 yen  
  EPS Diluted       20.45 yen           28.89 yen                   
  Ann Div                               84.00 yen        84.50 yen  
  -Q2 div                               42.00 yen        42.25 yen  
  -Q4 div                               42.00 yen        42.25 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T